Disease | calciphylaxis |
Comorbidity | C0022661|end-stage renal disease |
Sentences | 12 |
PubMedID- 21423552 | Slowly progressive metastatic calcifications are much more common than calciphylaxis in patients with end-stage renal disease. |
PubMedID- 26498285 | Marcescens necrotizing fasciitis in the setting of calciphylaxis associated with end-stage renal disease. |
PubMedID- 23716795 | Non-calcium/non-aluminum-containing phosphate binders like sevelamer hydrochloride or lanthanum carbonate should be preferred in calciphylaxis patients with end-stage renal disease. |
PubMedID- 25477966 | Tumour calcification and calciphylaxis in end-stage renal disease. |
PubMedID- 23663061 | Although calciphylaxis is normally associated with end-stage renal disease, calciphylaxis from non-uremic origin occurs as well. |
PubMedID- 25709494 | calciphylaxis in end-stage renal disease prior to dialytic treatment: a case report and literature review. |
PubMedID- 22805222 | calciphylaxis in end-stage renal disease patients. |
PubMedID- 25566898 | Aggressive calciphylaxis in end-stage renal disease after a failed kidney allograft. |
PubMedID- 25818988 | Clinical features, therapy, and outcome of calciphylaxis in patients with end-stage renal disease on renal replacement therapy: case series. |
PubMedID- 23782317 | Diffuse dermal angiomatosis associated with calciphylaxis in a patient with end-stage renal disease. |
PubMedID- 21652561 | Warfarin-induced pulmonary metastatic calcification and calciphylaxis in a patient with end-stage renal disease. |
PubMedID- 25720849 | Vitamin k antagonists predispose to calciphylaxis in patients with end-stage renal disease. |
Page: 1